Lymph directing prodrugs
US11738087B2 · kind B2 · utility
0Cited by
14References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2016 |
| Grant date | Aug 29, 2023 |
| Priority date | — |
| Expiry date | Mar 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and their uses, in particular, compounds in the form of prodrugs that pro mote transport of a pharmaceutical agent to the lymphatic system and subsequently enhance release of the parent drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.